PNC Financial Services Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $24.7K | Sell |
7,081
-1,586
| -18% | -$7.04K | ﹤0.01% | 3713 |
|
|
2026
Q2 | $47K | Buy |
8,667
+2,626
| +43% | +$10.1K | ﹤0.01% | 3326 |
|
|
2026
Q1 | $13.8K | Buy |
6,041
+3,967
| +191% | +$12.6K | ﹤0.01% | 3804 |
|
|
2025
Q4 | $8.3K | Buy |
2,074
+1,762
| +565% | +$9.8K | ﹤0.01% | 4010 |
|
|
2025
Q3 | $2.64K | Sell |
312
-152
| -33% | -$1.48K | ﹤0.01% | 4402 |
|
|
2025
Q2 | $5.22K | Buy |
464
+161
| +53% | +$1.48K | ﹤0.01% | 4080 |
|
|
2025
Q1 | $2.87K | Sell |
303
-112
| -27% | -$1.13K | ﹤0.01% | 4235 |
|
|
2024
Q4 | $4.67K | Sell |
415
-131
| -24% | -$2.3K | ﹤0.01% | 4042 |
|
|
2024
Q3 | $15.4K | Buy |
546
+445
| +441% | +$11.5K | ﹤0.01% | 3587 |
|
|
2024
Q2 | $1.93K | Sell |
101
-4,739
| -98% | -$121K | ﹤0.01% | 4246 |
|
|
2024
Q1 | $159K | Buy |
4,840
+4,529
| +1,456% | +$145K | ﹤0.01% | 2204 |
|
|
2023
Q4 | $10.3K | Buy |
311
+67
| +27% | +$1.9K | ﹤0.01% | 3675 |
|
|
2023
Q3 | $6.64K | Sell |
244
-300
| -55% | -$8.34K | ﹤0.01% | 3877 |
|
|
2023
Q2 | $16.5K | Sell |
544
-269
| -33% | -$8.7K | ﹤0.01% | 3573 |
|
|
2023
Q1 | $26.4K | Sell |
813
-69
| -8% | -$2.18K | ﹤0.01% | 3291 |
|
|
2022
Q4 | $24.8K | Sell |
882
-41
| -4% | -$1.18K | ﹤0.01% | 3309 |
|
|
2022
Q3 | $34K | Buy |
923
+537
| +139% | +$18.9K | ﹤0.01% | 3128 |
|
|
2022
Q2 | $12K | Buy |
386
+113
| +41% | +$3.29K | ﹤0.01% | 3672 |
|
|
2022
Q1 | $9K | Buy |
273
+185
| +210% | +$4.84K | ﹤0.01% | 3812 |
|
|
2021
Q4 | $3K | Sell |
88
-431
| -83% | -$12.4K | ﹤0.01% | 4046 |
|
|
2021
Q3 | $16K | Buy |
519
+394
| +315% | +$9.46K | ﹤0.01% | 3547 |
|
|
2021
Q2 | $3K | Buy |
125
+102
| +443% | +$2.04K | ﹤0.01% | 3955 |
|
|
2021
Q1 | $0 | Hold |
23
| – | – | ﹤0.01% | 4134 |
|
|
2020
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 3991 |
|
|
2020
Q3 | $0 | Sell |
23
-28
| -55% | – | ﹤0.01% | 3954 |
|
|
2020
Q2 | $0 | Sell |
51
-5,796
| -99% | -$38.8K | ﹤0.01% | 3949 |
|
|
2020
Q1 | $31K | Hold |
5,847
| – | – | ﹤0.01% | 2832 |
|
|
2019
Q4 | $53K | Hold |
5,847
| – | – | ﹤0.01% | 2772 |
|
|
2019
Q3 | $42K | Buy |
5,847
+23
| +0.4% | +$165 | ﹤0.01% | 2927 |
|
|
2019
Q2 | $46K | Sell |
5,824
-4,350
| -43% | -$51.5K | ﹤0.01% | 2893 |
|
|
2019
Q1 | $128K | Sell |
10,174
-3,704
| -27% | -$58.6K | ﹤0.01% | 2291 |
|
|
2018
Q4 | $276K | Buy |
13,878
+4,350
| +46% | +$101K | ﹤0.01% | 1749 |
|
|
2018
Q3 | $270K | Buy |
9,528
+2,448
| +35% | +$58.4K | ﹤0.01% | 1897 |
|
|
2018
Q2 | $149K | Buy |
7,080
+918
| +15% | +$17.4K | ﹤0.01% | 2236 |
|
|
2018
Q1 | $88K | Sell |
6,162
-8,078
| -57% | -$116K | ﹤0.01% | 2508 |
|
|
2017
Q4 | $176K | Buy |
14,240
+4,570
| +47% | +$64.4K | ﹤0.01% | 2113 |
|
|
2017
Q3 | $172K | Hold |
9,670
| – | – | ﹤0.01% | 2076 |
|
|
2017
Q2 | $245K | Buy |
9,670
+6,670
| +222% | +$160K | ﹤0.01% | 1864 |
|
|
2017
Q1 | $67K | Hold |
3,000
| – | – | ﹤0.01% | 2607 |
|
|
2016
Q4 | $44K | Buy |
3,000
+1,000
| +50% | +$19.7K | ﹤0.01% | 2795 |
|
|
2016
Q3 | $49K | Hold |
2,000
| – | – | ﹤0.01% | 2718 |
|
|
2016
Q2 | $38K | Hold |
2,000
| – | – | ﹤0.01% | 2871 |
|
|
2016
Q1 | $21K | Hold |
2,000
| – | – | ﹤0.01% | 3167 |
|
|
2015
Q4 | $24K | Hold |
2,000
| – | – | ﹤0.01% | 3132 |
|
|
2015
Q3 | $32K | Buy |
+2,000
| New | +$39K | ﹤0.01% | 3013 |
|
Other funds holding EVH
PNC Financial Services Group's EVH Position: Q3 2026 in Review
PNC Financial Services Group reduced its Evolent Health (EVH) stake by 18% in Q3 2026, selling an estimated $7.04K and leaving 7,081 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.
PNC Financial Services Group first reported a position in EVH in Q3 2015 and has held it in 45 quarters since. The position peaked at $276K in Q4 2018. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.
- PNC Financial Services Group held 7,081 shares of Evolent Health worth $24.7K as of Q3 2026.
- PNC Financial Services Group sold 1,586 Evolent Health shares in Q3 2026, an estimated $7.04K.
- Evolent Health made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3713 holding.
- PNC Financial Services Group first reported a position in Evolent Health in Q3 2015 and has held it in 45 quarters since.
- PNC Financial Services Group's Evolent Health position peaked at $276K in Q4 2018.
- 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.